Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Depomed Inc (DEPO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 339,516
  • Shares Outstanding, K 62,990
  • Annual Sales, $ 455,900 K
  • Annual Income, $ -88,720 K
  • 36-Month Beta 1.19
  • Price/Sales 0.73
  • Price/Cash Flow 8.44
  • Price/Book 1.56

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.93 +8.32%
on 10/13/17
6.49 -17.72%
on 10/03/17
-0.65 (-10.85%)
since 09/19/17
3-Month
4.93 +8.32%
on 10/13/17
10.97 -51.32%
on 07/26/17
-5.04 (-48.55%)
since 07/19/17
52-Week
4.93 +8.32%
on 10/13/17
24.09 -77.83%
on 10/21/16
-18.21 (-77.32%)
since 10/19/16

Most Recent Stories

More News
Robbins Arroyo LLP: Depomed, Inc. (DEPO) Misled Shareholders According to a Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Depomed, Inc. (NasdaqGS: DEPO). The complaint is brought on behalf of all purchasers...

DEPO : 5.34 (-0.93%)
Depomed Announces Appointment of Santosh J. Vetticaden, M.D., PH.D. as Senior Vice President, Chief Medical and Scientific Officer

Depomed, Inc. (NASDAQ:DEPO) today announced that Santosh J. Vetticaden, M.D., Ph.D., has joined Depomed as Senior Vice President, Chief Medical and Scientific Officer.

DEPO : 5.34 (-0.93%)
DEADLINE TODAY: Lundin Law PC Announces Securities Class Action Lawsuit against Depomed, Inc. and Reminds Investors with Losses In Excess of $500,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 17, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Depomed, Inc. ("Depomed" or the "Company") (NASDAQ: DEPO) for possible...

DEPO : 5.34 (-0.93%)
EQUITY ALERT: Goldberg Law PC Announces a Securities Class Action Lawsuit against Depomed, Inc. and Encourages Investors with Losses Exceeding $500,000 to Contact the Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Depomed, Inc. ("Depomed" or the "Company") (Nasdaq:DEPO) for violations of §§10(b)...

DEPO : 5.34 (-0.93%)
Reminder Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Depomed, Inc. (DEPO)

Law Offices of Howard G. Smith reminds investors of the October 17, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Depomed, Inc. ("Depomed"...

DEPO : 5.34 (-0.93%)
DEPO FINAL DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Depomed, Inc. (DEPO) & Lead Plaintiff Deadline: October 17, 2017

NEW YORK, NY / ACCESSWIRE / October 16, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against of Depomed, Inc. ("Depomed" or the "Company") (NASDAQ:...

DEPO : 5.34 (-0.93%)
DEADLINE TOMORROW: Khang & Khang LLP Announces Securities Class Action Lawsuit against Depomed, Inc. and Reminds Investors with Losses to Contact the Firm

IRVINE, CA / ACCESSWIRE / October 16, 2017 / Khang & Khang LLP (the "Firm") announces a securities class action lawsuit against Depomed, Inc. ("Depomed" or the "Company") (NASDAQ: DEPO). Investors, who...

DEPO : 5.34 (-0.93%)
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Depomed, Inc. (DEPO)

Glancy Prongay & Murray LLP ("GPM") reminds investors of the October 17, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased...

DEPO : 5.34 (-0.93%)
DEPO DEADLINE TOMORROW: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Depomed, Inc. and a Lead Plaintiff Deadline of October 17, 2017

NEW YORK, NY / ACCESSWIRE / October 16, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Northern District of California...

DEPO : 5.34 (-0.93%)
DEADLINE TUESDAY: Lundin Law PC Announces Securities Class Action Lawsuit against Depomed, Inc. and Reminds Investors with Losses to Contact the Firm

Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Depomed, Inc. ("Depomed" or the "Company") (Nasdaq:DEPO) for possible violations of federal securities laws from February...

DEPO : 5.34 (-0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects,...

See More

Support & Resistance

2nd Resistance Point 5.55
1st Resistance Point 5.47
Last Price 5.34
1st Support Level 5.24
2nd Support Level 5.09

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart